Ipilimumab plus nivolumab for patients with metastatic uveal melanoma: a multicenter, retrospective study (vol 8, e000331, 2020)

被引：0
|
作者：
Najjar, Y. G.
Navrazhina, K.
Ding, F.
Puzanov, Igor
机构：
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2020年 / 8卷 / 02期
关键词：
D O I：
10.1136/jitc-2019-000331corr1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Ipilimumab plus nivolumab for patients with metastatic uveal melanoma: a multicenter, retrospective study
    Najjar, Yana G.
    Navrazhina, Kristina
    Ding, Fei
    Bhatia, Roma
    Tsai, Katy
    Abbate, Kelly
    Durden, Barbara
    Eroglu, Zeynep
    Bhatia, Shailender
    Park, Song
    Chowdhary, Akansha
    Chandra, Sunandana
    Kennedy, Jonathan
    Ernstoff, Marc
    Vachhani, Pankit
    Drabick, Joseph
    Singh, Arun
    Xu, Tan
    Yang, Jessica
    Carvajal, Richard
    Manson, Daniel
    Kirkwood, John
    Cohen, Justine
    Sullivan, Ryan
    Johnson, Douglas
    Funchain, Pauline
    Shoushtari, Alexander
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
  • [2] Nivolumab for metastatic uveal melanoma: a multicenter, retrospective study
    Tacar, Seher Yildiz
    Selcukbiricik, Fatih
    Yilmaz, Mesut
    Erturk, Kayhan
    Sarici, Ahmet Murat
    Gulturk, Ilkay
    Ayhan, Murat
    Tural, Deniz
    MELANOMA RESEARCH, 2021, 31 (05) : 449 - 455
  • [3] Nivolumab plus ipilimumab in metastatic uveal melanoma: a real-life, retrospective cohort of 47 patients
    Salaun, Helene
    de Koning, Leanne
    Saint-Ghislain, Mathilde
    Servois, Vincent
    Ramtohul, Toulsie
    Garcia, Agathe
    Matet, Alexandre
    Cassoux, Nathalie
    Mariani, Pascale
    Piperno-Neumann, Sophie
    Rodrigues, Manuel
    ONCOIMMUNOLOGY, 2022, 11 (01):
  • [4] Pilot Trial of Arginine Deprivation Plus Nivolumab and Ipilimumab in Patients with Metastatic Uveal Melanoma
    Kraehenbuehl, Lukas
    Holland, Aliya
    Armstrong, Emma
    O'Shea, Sirinya
    Mangarin, Levi
    Chekalil, Sara
    Johnston, Amanda
    Bomalaski, John S.
    Erinjeri, Joseph P.
    Barker, Christopher A.
    Francis, Jasmine H.
    Wolchok, Jedd D.
    Merghoub, Taha
    Shoushtari, Alexander N.
    CANCERS, 2022, 14 (11)
  • [5] Nivolumab for patients with metastatic uveal melanoma previously untreated with ipilimumab: A single-institutional retrospective study
    Namikawa, K.
    Takahashi, A.
    Tsutsumida, A.
    Mori, T.
    Motoi, N.
    Jinnai, S.
    Kage, Y.
    Muto, Y.
    Nakano, E.
    Yamazaki, N.
    ANNALS OF ONCOLOGY, 2017, 28 : 114 - 114
  • [6] Nivolumab for patients with metastatic uveal melanoma previously untreated with ipilimumab: a single-institution retrospective study
    Namikawa, Kenjiro
    Takahashi, Akira
    Mori, Taisuke
    Tsutsumida, Arata
    Suzuki, Shigenobu
    Motoi, Noriko
    Jinnai, Shunichi
    Kage, Yuta
    Mizuta, Haruki
    Muto, Yusuke
    Nakano, Eiji
    Yamazaki, Naoya
    MELANOMA RESEARCH, 2020, 30 (01) : 76 - 84
  • [7] Toxicity and response to ipilimumab and nivolumab in elderly patients with metastatic melanoma: A multicenter retrospective analysis.
    Pathmanathan, Shivanshan
    Babu, Hari S.
    Dzienis, Marcin Radoslaw
    Azer, Mary
    Eastgate, Melissa A.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [8] Clinical characteristics of responders to nivolumab plus ipilimumab (Nivo/Ipi) in metastatic uveal melanoma.
    Shephard, Michael Paul
    Glover, Maura
    Balmes, Gener
    Cain, Suzanne
    Vardeleon, Anna
    Mouton, Rosalind
    Posada, Liberty
    Simien, Rinata
    Hwu, Patrick
    Davies, Michael
    Yee, Cassian
    Wong, Michael
    Tawbi, Hussein
    Woodman, Scott
    Amaria, Rodabe
    Diab, Adi
    Glitza, Isabella
    Hwu, Wen-Jen
    Patel, Sapna
    CANCER RESEARCH, 2020, 80 (19) : 38 - 38
  • [9] Phase II study of ipilimumab and nivolumab (ipi/nivo) in metastatic uveal melanoma (UM).
    Pelster, Meredith
    Gruschkus, Stephen K.
    Bassett, Roland
    Gombos, Dan S.
    Shephard, Michael
    Posada, Liberty
    Glover, Maura
    Diab, Adi
    Hwu, Patrick
    Patel, Sapna Pradyuman
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [10] Efficacy and Safety of Nivolumab Plus Ipilimumab for Metastatic Renal Cell Carcinoma in Patients 75 Years and Older: Multicenter Retrospective Study
    Yamashita, Shimpei
    Hamamoto, Shuzo
    Furukawa, Junya
    Fujita, Kazutoshi
    Takahashi, Masayuki
    Miyake, Makito
    Ito, Noriyuki
    Iwamoto, Hideto
    Kohjimoto, Yasuo
    Hara, Isao
    CANCERS, 2025, 17 (03)
12345